Encyclopedia of Metalloproteins

2013 Edition
| Editors: Robert H. Kretsinger, Vladimir N. Uversky, Eugene A. Permyakov

Boron-containing Compounds, Regulation of Therapeutic Potential

  • Ion Romulus Scorei
Reference work entry
DOI: https://doi.org/10.1007/978-1-4614-1533-6_482



Boron is a micronutrient element necessary for the growth and development of vascular plants, marine algae and algal flagellates, diatoms, and cyanobacteria. Although boron has not been yet shown to be an essential nutrient in animal cells, more data will probably support this role in the future.

Boron compounds with therapeutic potential are the inorganic or organic compounds that contain boron as an integral part of the molecule and possess interesting pharmacological properties like hypolipidemic, anti-inflammatory, anti-osteoporosis, and antineoplastic.


Boron (B) has been shown to possess the following characteristics: (1) It is a cell signaling molecule. (2) It is a co-factor of the enzymes it regulates. (3) It is a nonenzymatic cofactor. (4) It plays both structural and functional...

This is a preview of subscription content, log in to check access.


  1. Baker SJ, Tomshob JW, Benkovicc SJ (2011) Boron-containing inhibitors of synthetases. Chem Soc Rev 40:4279–4285PubMedCrossRefGoogle Scholar
  2. Barranco WT, Eckhert CD (2004) Boric acid inhibits human prostate cancer cell proliferation. Cancer Lett 216(1):21–29PubMedCrossRefGoogle Scholar
  3. Dembitsky VM, Smoum R, Al-Quntar AAA, Ali HA, Pergament I, Srebnik M (2002) Natural occurrence of boron-containing compounds in plants, algae and microorganisms. Plant Sci 163:931–942CrossRefGoogle Scholar
  4. Dembitsky VM, Al-Quntar AAA, Srebnik M (2011) Natural and synthetic small boron-containing molecules as potential inhibitors of bacterial and fungal quorum sensing. Chem Rev 111:209–237PubMedCrossRefGoogle Scholar
  5. Devirian T, Volpe S (2003) The physiological effects of dietary boron. Crit Rev Food Sci Nutr 43:219–223PubMedCrossRefGoogle Scholar
  6. Gabel SA, London RE (2008) Ternary borate-nucleoside complex stabilization by Ribonuclease A demonstrates phosphate mimicry. J Biol Inorg Chem 13(2):207–217PubMedCrossRefGoogle Scholar
  7. Groziak MP (2001) Boron therapeutics on the horizon. Am J Ther 8:321–328PubMedCrossRefGoogle Scholar
  8. Hosmane NS (ed) (2011) Boron science: new technologies and applications. CRC Press/Northern Illinois University, DekalbGoogle Scholar
  9. Hunt CD (1996) Biochemical effects of physiological amounts of dietary boron. J Trace Elem Exp Med 9(4):185–213CrossRefGoogle Scholar
  10. Lowery CA, Salzameda NT, Sawada D, Kaufmann GF, Janda KD (2010) Medicinal chemistry as a conduit for the modulation of quorum sensing. J Med Chem 53(21):7467–7489PubMedCrossRefGoogle Scholar
  11. McAuley EM, Bradke TA, Plopper GE (2012) Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration. Cell Adh Migr 5:382–386CrossRefGoogle Scholar
  12. Meacham S, Karakas S, Wallace A, Altun F (2010) Boron in human health: evidence for dietary recommendations and public policies. Open Miner Process J 3:36–53Google Scholar
  13. Nielsen FH (2008) Is boron nutritionally relevant? Nutr Rev 66:183–191PubMedCrossRefGoogle Scholar
  14. Nielsen F, Meacham S (2011) Growing evidence for human health benefits of boron. J Evid Based Complement Alternat Med. doi:10.1177/2156587211407638Google Scholar
  15. Paramore A, Frantz S (2003) Bortezomib. Nat Rev Drug Discov 2:611–612PubMedCrossRefGoogle Scholar
  16. Park M, Li Q, Shcheynikov N, Muallen S, Zeng W (2005) Borate transport and cell growth and proliferation: not only in plants. Cell Cycle 4(1):24–26PubMedCrossRefGoogle Scholar
  17. Scorei R (2011) Boron compounds in the breast cancer cells chemoprevention and chemotherapy. In: Gunduz E, Gunduz M (eds) Breast cancer – current and alternative therapeutic modalities. InTech, Rijeca, pp 91–114Google Scholar
  18. Scorei R (2012) Is boron a prebiotic element? A mini-review of the essentiality of boron for the appearance of life on Earth. Orig Life Evol Biosph 42(1):3–17.PubMedCrossRefGoogle Scholar
  19. Scorei R, Popa R (2010) Boron-containing compounds as preventive and chemotherapeutic agents for cancer. Anti-Cancer Agents Med Chem 10:346–351CrossRefGoogle Scholar
  20. Scorei RI, Rotaru P (2011) Calcium fructoborate – potential anti-inflammatory agent. Biol Trace Elem Res 143(3):1223–1238PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of BiochemistryUniversity of CraiovaCraiovaRomania